Status:
UNKNOWN
RayOne EMV Mini-monovision - Efficiency and Safety of 3 Grades of Mini-monovision
Lead Sponsor:
Somich, s.r.o.
Conditions:
Cataract Senile
Presbyopia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Aim:To determine the effectiveness and subjective satisfaction of patients with bilateral cataract surgery and implantation of intraocular lens (IOL) RayOne EMV with enhanced optic, using different de...
Detailed Description
Purpose: To determine the effectiveness and subjective satisfaction of patients with bilateral cataract surgery and implantation of intraocular lens (IOL) RayOne EMV with enhanced optic, using differe...
Eligibility Criteria
Inclusion
- \- bilateral senile cataract
Exclusion
- corneal astigmatism greater than 0.75 diopters (D)
- difference in the planned dioptric value of intraocular lens (IOL) over 2 D (calculated for bilateral emetropia)
- perioperative complications not allowing proper implantation and centering of IOL in the lens bag
- time between surgeries of both eyes greater than 1 month
- eye disease, which could reduce visual acuity
- previous refractive surgeries
- systemic diseases that could affect postoperative visual acuity
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 21 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05417633
Start Date
January 1 2022
End Date
March 21 2023
Last Update
June 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Somich
Karlovy Vary, Czechia, 36006